SCHEMBL265030

SCHEMBL265030

CC(N)c1ccc2[nH]c(=O)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.48
ALDH1A1 P00352 2/20 0.48
GRIA1 P42261 4/20 0.46
CACNG8 Q8WXS5 4/20 0.46
GAA P10253 3/20 0.46
PKM P14618 1/20 0.46
PDE3B Q13370 2/20 0.41
PDE3A Q14432 2/20 0.41
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ADRB2 P07550 1/20 0.38
MEN1 O00255 1/20 0.37
SMYD3 Q9H7B4 1/20 0.37
PIK3CD O00329 1/20 0.36
ABL1 P00519 1/20 0.36
EGFR P00533 1/20 0.36
HCK P08631 1/20 0.36
SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL265008 0.98 GAA (0.49) MAPTALDH1A1GRIA1CACNG8GAA
SCHEMBL4569783 0.84 MAPT (0.58) MAPTALDH1A1GRIA1CACNG8GAA
SCHEMBL29910923 0.84 MAPT (0.58) MAPTALDH1A1GRIA1CACNG8GAA
SCHEMBL19880496 0.78 MAPT (0.46) MAPTALDH1A1GRIA1CACNG8GAA
SCHEMBL13969591 0.78 ALDH1A1 (0.48) MAPTALDH1A1GAAPKMKMT2A
SCHEMBL4136607 0.77 PTGS2 (0.55) MAPTALDH1A1KMT2AMEN1
SCHEMBL5286978 0.77 HSD17B10 (0.50) MAPTALDH1A1GRIA1CACNG8GAA
SCHEMBL18500486 0.76 PKM (0.44) MAPTALDH1A1GRIA1CACNG8GAA
SCHEMBL12658621 0.75 SMN1; SMN2 (0.44) MAPTALDH1A1GAAPKMKMT2A
SCHEMBL9768319 0.75 MAPT (0.47) MAPTALDH1A1GRIA1CACNG8GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134004-B2 Substituted N-bicyclicalkyl bicycliccarboxyamide compounds PFIZER INC. (US) 2012-03-13 US disclosed
US-20090253740-A1 SUBSTITUTED N-BICYCLICALKYL BICYCLICCARBOXYAMIDE COMPOUNDS PFIZER INC 2009-10-08 US disclosed
US-7514457-B2 Substituted aryloxymethyl bicyclicmethyl acetamide compounds PFIZER INC. (US) 2009-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253740-A1 SUBSTITUTED N-BICYCLICALKYL BICYCLICCARBOXYAMIDE COMPOUNDS OPRL1, CNR1, TRPV1 MAPT 4405/4885ALDH1A1 986/4885GRIA1 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.